Healthy Skepticism Library item: 10575
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Vagelos PR.
Innovation and industry-academia interactions: where conflicts arise and measures to avoid them.
Cleve Clin J Med 2007 Mar; 74:
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17469468&dopt=Abstract
Abstract:
Every phase of the development of biopharmaceuticals and medical devices has the potential for conflict of interest, but adherence to established rules and practices throughout product development can eliminate the possibility of conflicts. Adherence to good practices should continue through the postmarketing period, with swift reporting and vigorous investigation of any safety concerns. Although some academic medical centers are restricting interactions between their faculty and industry to prevent possible conflicts in physician education about new products, industry and academia should look for new ways to come together in mutually agreed forums that focus on educating clinicians about new products in an efficient, transparent way.
Keywords:
MeSH Terms:
Academic Medical Centers/economics
Academic Medical Centers/ethics*
Biomedical Research/economics
Biomedical Research/ethics*
Conflict of Interest*
Diffusion of Innovation
Drug Design
Drug Industry/ethics
Entrepreneurship/economics
Entrepreneurship/ethics*
Equipment and Supplies
Faculty, Medical/standards*
Health Care Sector/ethics*
Humans
Safety
United States
